Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | GAA | P10253 | 3/20 | 0.49 |
| ▸ | HSPA5 | P11021 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | CA2 | P00918 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | TYR | P14679 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | BLM | P54132 | 2/20 | 0.44 |
| ▸ | ATM | Q13315 | 2/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8854338 | 0.90 | CYP1A2 (0.61) | CYP1A2CYP2C9CYP2C19KMT2AGAA | |
| SCHEMBL30008257 | 0.90 | CYP1A2 (0.61) | CYP1A2CYP2C9CYP2C19KMT2AGAA | |
| SCHEMBL6899290 | 0.89 | CYP1A2 (0.52) | CYP1A2CYP2C9CYP2C19KMT2AGAA | |
| SCHEMBL163700 | 0.88 | GAA (0.58) | CYP1A2CYP2C9CYP2C19KMT2AGAA | |
| SCHEMBL27415103 | 0.88 | PTGS2 (0.50) | CYP1A2CYP2C9CYP2C19KMT2AGAA | |
| SCHEMBL9179728 | 0.87 | CYP1A2 (0.57) | CYP1A2CYP2C9CYP2C19KMT2AGAA | |
| SCHEMBL106347 | 0.86 | PTGS2 (0.51) | CYP1A2CYP2C9CYP2C19KMT2AGAA | |
| SCHEMBL27480119 | 0.86 | PTGS2 (0.51) | CYP1A2CYP2C9CYP2C19KMT2AGAA | |
| SCHEMBL11707644 | 0.86 | PTGS2 (0.51) | CYP1A2CYP2C9CYP2C19KMT2AGAA | |
| SCHEMBL27418722 | 0.86 | PTGS2 (0.51) | CYP1A2CYP2C9CYP2C19KMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116675925-A | Ionomer interlayers having enhanced adhesion properties | 可乐丽美国股份有限公司 | 2023-09-01 | — | — | CN | disclosed |
| CN-115702205-A | Oxymethylene copolymer resin composition and method for producing same | 三菱瓦斯化学株式会社 | 2023-02-14 | — | — | CN | disclosed |
| US-8518302-B2 | Stabilization of organic materials | BASF SE (DE) | 2013-08-27 | — | — | US | disclosed |
| US-8518302-B2 | Stabilization of organic materials | BASF SE (DE) | 2013-08-27 | — | — | US | disclosed |
| US-20120088869-A1 | STABILIZATION OF ORGANIC MATERIALS | GERSTER MICHELE (CH) | 2012-04-12 | — | — | US | disclosed |
| US-20120088869-A1 | STABILIZATION OF ORGANIC MATERIALS | GERSTER MICHELE (CH) | 2012-04-12 | — | — | US | disclosed |
| US-6242514-B1 | CYCLIC PHOSPHATE OR PHOSPHONATE; HEAT AND OXIDATION STABILIZER ESPECIALLY FOR OLEFIN POLYMERS AND ENGINEERING THERMOPLASTICS | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2001-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088869-A1 | STABILIZATION OF ORGANIC MATERIALS | LPO, AOX1, SOD1 | CYP1A2 262/4885CYP2C9 945/4885CYP2C19 635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.